VIRIDAXIS is a Belgian biotechnology company specialized in the mass production of parasitoids to control aphids.
VIRIDAXIS, a spin‑off of Louvain Catholic University, uses an innovative technology to mass-produce parasitoids. These are then supplied to Belgian and multinational companies operating in this sector. Expansion of its R&D activity now enables the company to develop new products and increase its production capacity.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 22, 2007 | Series B | $1.41M | 1 | — | — | Detail |